Cullinan Therapeutics, Inc. (CGEM)
NASDAQ · Healthcare
Cullinan Therapeutics, Inc. PS Ratio 2021–2026
Current and historical P/S ratio for Cullinan Therapeutics, Inc. (CGEM): market cap divided by trailing twelve-month revenue. As of March 31, 2022 it is 24.56.
From: 03/31/2022To: 09/30/2022
Stock Price
TTM Revenue
PS Ratio
Cullinan Therapeutics, Inc. PS Ratio — FAQ
Cullinan Therapeutics, Inc. (CGEM) ps ratio over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CGEM's ps ratio history?
The chart and table above show Cullinan Therapeutics, Inc.'s ps ratio by year and by quarter, including the growth rate.